⚡2DG Approved for Emergency Use as Adjunct Therapy for COVID-19 Patients, Says DRDO
By ANI
The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.